Denali Therapeutics Inc.【DNLI】 業績推移・財務諸表

(単位:千ドル) 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 641 1,648 1,195 125,676 4,205 4,197 13,604 4,672 3,604 5,847 9,393 7,923 22,939 5,285 42,141 52,480 3,559 35,141 294,123 1,267 - - - -
売上成長率(%) - - - - - - - -
研究開発費 20,819 52,134 30,321 - 37,403 51,884 52,544 - 51,016 53,152 53,704 60,207 65,711 71,559 86,098 92,737 87,786 128,816 97,520 89,737 107,016 91,399 98,238 116,227
営業費用 26,389 59,030 39,159 - 46,713 66,960 63,759 - 63,571 67,124 69,509 79,143 84,756 90,878 108,639 113,896 111,045 155,956 123,640 115,062 132,252 116,593 123,187 145,580
営業利益 -25,748 -57,382 -37,964 74,722 -42,508 -62,763 -50,155 -57,758 -59,967 -61,277 -60,116 -71,220 -61,817 -85,593 -66,498 -61,416 -107,486 -120,815 170,483 -113,795 -117,715 -116,593 -123,187 -145,580
営業利益率 (%) - - - -
経常(税引前)利益 - - - - - -58,650 -46,373 - -56,898 -58,679 -58,172 -70,041 -60,691 -84,588 - -58,767 -103,299 - 183,383 -99,353 - - - -
経常(税引前)利益率(%) - - - - - -1397.43 -340.88 - -1578.75 -1003.57 -619.31 -884.02 -264.58 -1600.53 - -111.98 -2902.47 - 62.35 -7841.59 - - - -
法人税等合計 - - - - - -300 -100 - -100 79 56 - - - - 27 - - - - - - - -
実効税率(%) - - - - - - - - - - - - - - - - - -
純利益 -23,678 -54,724 -35,371 77,533 -38,992 -58,337 -46,260 -54,025 -56,763 -58,758 -58,228 -70,041 -60,691 -84,588 -65,220 -58,794 -103,299 -109,781 183,383 -99,353 -101,802 -99,026 -107,192 -132,970
純利益率(%) - - - -
一株あたり利益 - - - - - - - - - - - -0.58 -0.5 -0.69 -0.53 -0.48 -0.84 -0.8 1.34 -0.72 -0.68 -0.59 -0.63 -0.78
希薄化後一株あたり利益 - - - - - - - - - - - -0.58 -0.5 -0.69 -0.53 -0.48 -0.84 -0.8 1.3 -0.72 -0.68 -0.59 -0.63 -0.78
EBITDA - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - -